Cargando…

Cyclin-Dependent Kinase Activity Controls the Onset of the HCMV Lytic Cycle

The onset of human cytomegalovirus (HCMV) lytic infection is strictly synchronized with the host cell cycle. Infected G0/G1 cells support viral immediate early (IE) gene expression and proceed to the G1/S boundary where they finally arrest. In contrast, S/G2 cells can be infected but effectively blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zydek, Martin, Hagemeier, Christian, Wiebusch, Lüder
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936547/
https://www.ncbi.nlm.nih.gov/pubmed/20844576
http://dx.doi.org/10.1371/journal.ppat.1001096
_version_ 1782186507145052160
author Zydek, Martin
Hagemeier, Christian
Wiebusch, Lüder
author_facet Zydek, Martin
Hagemeier, Christian
Wiebusch, Lüder
author_sort Zydek, Martin
collection PubMed
description The onset of human cytomegalovirus (HCMV) lytic infection is strictly synchronized with the host cell cycle. Infected G0/G1 cells support viral immediate early (IE) gene expression and proceed to the G1/S boundary where they finally arrest. In contrast, S/G2 cells can be infected but effectively block IE gene expression and this inhibition is not relieved until host cells have divided and reentered G1. During latent infection IE gene expression is also inhibited, and for reactivation to occur this block to IE gene expression must be overcome. It is only poorly understood which viral and/or cellular activities maintain the block to cell cycle or latency-associated viral IE gene repression and whether the two mechanisms may be linked. Here, we show that the block to IE gene expression during S and G2 phase can be overcome by both genotoxic stress and chemical inhibitors of cellular DNA replication, pointing to the involvement of checkpoint-dependent signaling pathways in controlling IE gene repression. Checkpoint-dependent rescue of IE expression strictly requires p53 and in the absence of checkpoint activation is mimicked by proteasomal inhibition in a p53 dependent manner. Requirement for the cyclin dependent kinase (CDK) inhibitor p21 downstream of p53 suggests a pivotal role for CDKs in controlling IE gene repression in S/G2 and treatment of S/G2 cells with the CDK inhibitor roscovitine alleviates IE repression independently of p53. Importantly, CDK inhibiton also overcomes the block to IE expression during quiescent infection of NTera2 (NT2) cells. Thus, a timely block to CDK activity not only secures phase specificity of the cell cycle dependent HCMV IE gene expression program, but in addition plays a hitherto unrecognized role in preventing the establishment of a latent-like state.
format Text
id pubmed-2936547
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29365472010-09-15 Cyclin-Dependent Kinase Activity Controls the Onset of the HCMV Lytic Cycle Zydek, Martin Hagemeier, Christian Wiebusch, Lüder PLoS Pathog Research Article The onset of human cytomegalovirus (HCMV) lytic infection is strictly synchronized with the host cell cycle. Infected G0/G1 cells support viral immediate early (IE) gene expression and proceed to the G1/S boundary where they finally arrest. In contrast, S/G2 cells can be infected but effectively block IE gene expression and this inhibition is not relieved until host cells have divided and reentered G1. During latent infection IE gene expression is also inhibited, and for reactivation to occur this block to IE gene expression must be overcome. It is only poorly understood which viral and/or cellular activities maintain the block to cell cycle or latency-associated viral IE gene repression and whether the two mechanisms may be linked. Here, we show that the block to IE gene expression during S and G2 phase can be overcome by both genotoxic stress and chemical inhibitors of cellular DNA replication, pointing to the involvement of checkpoint-dependent signaling pathways in controlling IE gene repression. Checkpoint-dependent rescue of IE expression strictly requires p53 and in the absence of checkpoint activation is mimicked by proteasomal inhibition in a p53 dependent manner. Requirement for the cyclin dependent kinase (CDK) inhibitor p21 downstream of p53 suggests a pivotal role for CDKs in controlling IE gene repression in S/G2 and treatment of S/G2 cells with the CDK inhibitor roscovitine alleviates IE repression independently of p53. Importantly, CDK inhibiton also overcomes the block to IE expression during quiescent infection of NTera2 (NT2) cells. Thus, a timely block to CDK activity not only secures phase specificity of the cell cycle dependent HCMV IE gene expression program, but in addition plays a hitherto unrecognized role in preventing the establishment of a latent-like state. Public Library of Science 2010-09-09 /pmc/articles/PMC2936547/ /pubmed/20844576 http://dx.doi.org/10.1371/journal.ppat.1001096 Text en Zydek et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zydek, Martin
Hagemeier, Christian
Wiebusch, Lüder
Cyclin-Dependent Kinase Activity Controls the Onset of the HCMV Lytic Cycle
title Cyclin-Dependent Kinase Activity Controls the Onset of the HCMV Lytic Cycle
title_full Cyclin-Dependent Kinase Activity Controls the Onset of the HCMV Lytic Cycle
title_fullStr Cyclin-Dependent Kinase Activity Controls the Onset of the HCMV Lytic Cycle
title_full_unstemmed Cyclin-Dependent Kinase Activity Controls the Onset of the HCMV Lytic Cycle
title_short Cyclin-Dependent Kinase Activity Controls the Onset of the HCMV Lytic Cycle
title_sort cyclin-dependent kinase activity controls the onset of the hcmv lytic cycle
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936547/
https://www.ncbi.nlm.nih.gov/pubmed/20844576
http://dx.doi.org/10.1371/journal.ppat.1001096
work_keys_str_mv AT zydekmartin cyclindependentkinaseactivitycontrolstheonsetofthehcmvlyticcycle
AT hagemeierchristian cyclindependentkinaseactivitycontrolstheonsetofthehcmvlyticcycle
AT wiebuschluder cyclindependentkinaseactivitycontrolstheonsetofthehcmvlyticcycle